20 November 2017
News and Views
Links and Services
The most recent issue of Gastroenterology investigates the influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors